Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXJC9Q
|
||||
| Drug Name |
2-(4-chloro-6-(naphthalen-2-ylamino)pyrimidin-2-ylthio)-2-(naphthalen-1-yl)acetic acid
|
||||
| Synonyms |
CHEMBL1091523
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H18ClN3O2S
|
||||
| Canonical SMILES |
OC(=O)C(Sc1nc(Cl)cc(Nc2ccc3ccccc3c2)n1)c4cccc5ccccc45
|
||||
| InChI |
InChI=1S/C26H18ClN3O2S/c27-22-15-23(28-19-13-12-16-6-1-2-8-18(16)14-19)30-26(29-22)33-24(25(31)32)21-11-5-9-17-7-3-4-10-20(17)21/h1-15,24H,(H,31,32)(H,28,29,30)
|
||||
| InChIKey |
FHLFDNGKWOUAFE-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Peroxisome proliferator activated receptor gamma | Target Info | [1587926] | ||
| Arachidonate 5-lipoxygenase | Target Info | [1587926] | |||
| PANTHER Pathway | CCKR signaling map ST | ||||
| PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
| WikiPathways | Wnt Signaling Pathway Netpath | ||||
| Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
| Differentiation of white and brown adipocyte | |||||
| Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
| Transcriptional Regulation of White Adipocyte Differentiation | |||||
| Adipogenesis | |||||
| SREBP signalling | |||||
| Nuclear ReceptorsWP2877:Vitamin D Receptor Pathway | |||||
| Arachidonic acid metabolism | |||||
| Eicosanoid Synthesis | |||||
| Selenium Micronutrient Network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.